Total embolization of the main splenic artery as a supplemental treatment modality for hypersplenism

Table 1 Outcomes of total embolization of the main splenic artery in 15 patients

Pa./age (yr)/sex	Virus	Child-Pugh	WBC count (× 109/L)						Platelets (× 109/L)						Splenic volumn (cm3)						Complication	Follow-up (mo)	Out-comes
			Pre-EM	1 mo	6 mo	1 yr	2 yr	3 yr	Pre-EM	1 mo	6 mo	1 yr	2 yr	3 yr	Pre-EM	1 mo	6 mo	1 yr	2 yr	3 yr
1/48/F	B	A	1.3	7.8	6.5	5.3	4.9	5.1	35	181	142	136	132	128	829	367	265	265	312	312	AP, F, V	52	Alive
2/52/M	B	B	1.8	9.8	5.3	5.6	5.6	4.4	24	191	156	148	145	139	768	258	326	326	326	367	F, V	48	Alive
3/60/M	B	A	1.6	8.6	6.5	6.3	4.2	6.4	33	233	185	157	132	142	869	369	328	328	328	305	AP, F	47	Alive
4/51/M	B	A	1.8	8.3	5.4	7.2	6.2	4.6	45	173	158	156	148	132	815	289	289	287	250	285	F, V	45	Alive
5/34/F	B	A	1.1	7.8	7.2	6.8	5.2	4.5	48	165	161	152	153	148	724	366	242	235	235	235	AP, V	41	Alive
6/49/M	B	C	1.4	8.6	4.8	4.6	4.4	4.8	43	144	43	139	132	123	698	278	278	278	278	278	AP, V	40	Alive
7/50/F	B	A	1.5	8.5	5.8	4.8	4.6	4.2	25	156	145	146	134	129	758	325	325	312	314	314		37	Alive
8/59/M	C	B	1.1	7.8	6.3	6.7	7.3	4.8	36	143	145	132	128	132	846	319	319	310	310	310	AP, F, V	36	Alive
9/28/M	B	A	1.5	9.6	6	5.1	5.2	5.3	48	213	167	164	156	147	687	247	247	247	249	276	AP, F,	36	Alive
10/55/M	B	A	0.8	7.3	6.9	5.6	5.4	4.5	32	121	125	131	128	124	784	305	305	298	320	320	AP, F, V	42	Alive
11/58/F	B	C	1.7	6.8	8.5	6.8	3.9	4.2	26	163	184	146	139	132	755	362	362	362	362	345	AP, F	38	Alive
12/46/M	B	A	0.9	5.3	4.8	3.8	4.5		48	146	135	141	136		732	247	285	285	285		AP, F, V	28	Alive
13/58/F	C	A	1.2	8.2	3.8	4.8	5		32	153	138	146	134		848	328	328	318	315		AP, F	30	Alive
14/55/M	B	B	1.4	8.3	5.2	4.5	4.4		35	164	176	163	165		683	361	356	346	327			26	Alive
15/48/M	B	A	1.6	8.8	6.3	6.2	6.4		38	241	220	168	137		752	298	305	315	315		AP, F	24	Alive

Pre-EM: Pre-embolization; AP: Abdominal pain; F: Fever; V: Vomiting; WBC: White blood cell.